狠狠色丁香久久综合婷婷亚洲成人福利在线-欧美日韩在线观看免费-国产99久久久久久免费看-国产欧美在线一区二区三区-欧美精品一区二区三区免费观看-国内精品99亚洲免费高清

      

        

            
		
		
      		
            
			
            
				
            
					
            
						
            
							
            
								
								
            深圳遠(yuǎn)揚化學(xué)技術(shù)有限公司
                                                                        
            
										  中級會員 | 第10年									
            
                                    								
            

							
            
						
            
                        

					
            
										
            
						
            
                            							
            
								
            
								
            
									
            15012456311
            
								
            
							
            
                            						
            
					
            
										
				
            
			
            
			
            
				
            
					
				
            
			
            
		
            

		
		 
				
            
			
            
				
			
            
		
            
		
            
			
            
				
            
					
            利拉利汀雜質(zhì)對照品 
            
					
                                
					                        
						
            
                        
            
                            						        
            
							    
							    								    
            參   考   價:
									    										    											    ￥ 100
										    									    								    
            
								    									    
            訂  貨  量: 										    											    											    												    ≥1 
										    									    
            
								    							    								
            具體成交價以合同協(xié)議為準(zhǔn)
            
						    
            
                            						    
							    
            
								    
            
									    
            產(chǎn)品型號
            
									    
            品       牌其他品牌
            
		                                
            廠商性質(zhì)生產(chǎn)商
            
		                                									    
            所  在  地深圳市
            
								    
            
								    
                                    
            
                                                                             
            
								    
            
									    
            
										    更新時間：2016-04-29 11:23:04瀏覽次數(shù)：843次
									    
            
									    聯(lián)系我時，請告知來自 化工儀器網(wǎng)
								    
            
						    
            
						    
                        
            
											
            
                        
					                    
            			 
				
            
			
            
		
            
		
            
			
            
				
            
					
            
						同類優(yōu)質(zhì)產(chǎn)品更多>
					
            
					
				
            
			
            
		
            
		
            
			
            
				
            
					
				    
            
				        				        
				        
            
				            
            
				                
            
				                    				                
            
				            
            
				            
            
				            利拉利汀雜質(zhì)對照品
            提供NMR，HPLC，MS圖譜及COA證書，新藥申報可用
            Linagliptin Impurity
            全部雜質(zhì)現(xiàn)貨供應(yīng)，*，并可接受定制。
            
				        
				        
            
				            
            利拉利汀雜質(zhì)對照品?    產(chǎn)品介紹：
            規(guī)格：10mg/25mg/50mg/100mg等多種規(guī)格可選。
            用途：實驗研發(fā)，藥品申報檢測，不得用于臨床醫(yī)學(xué)診斷。
            隨貨提供：所有雜質(zhì)對照品均隨貨提供HPLC，NMR，MS圖譜及CoA證書。
             
            國產(chǎn)進(jìn)口品牌皆有銷售，產(chǎn)品庫時常會有更新，另外，我司有專業(yè)研發(fā)團(tuán)隊，可提供部分雜質(zhì)定制服務(wù)，以zui大可能的滿足您雜質(zhì)對照品的選購需求。
             
            利拉利汀雜質(zhì)對照品     雜質(zhì)列表：
            Linagliptin(R)-8-(3-aminopiperidin-1-yl)-7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione
            Linagliptin Impurity 1 7-(but-2-yn-1-yl)-8-((2-hydroxyethyl)amino)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione
            Linagliptin Impurity 22-((R)-3-aminopiperidine-1-carbonyl)-N-((R)-1-(7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)benzamide
            Linagliptin Impurity 3(R)-7-(but-2-yn-1-yl)-8-(3-(1,3-dioxoisoindolin-2-yl)piperidin-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione
            Linagliptin Impurity 4(R,Z)-8-(3-aminopiperidin-1-yl)-7-(3-bromobut-2-en-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione
            Linagliptin Impurity 5N1,N2-bis((R)-1-(7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)phthalamide
            Linagliptin Impurity 6(R)-2-((1-(7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)carbamoyl)benzoic acid
            Linagliptin Impurity 78-((R)-3-aminopiperidin-1-yl)-7-((R)-buta-1,2-dien-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione compound with 8-((R)-3-aminopiperidin-1-yl)-7-((S)-buta-1,2-dien-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione (1:1)
            Linagliptin Impurity 8(R)-N-(1-(7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)acetamide
            Linagliptin Impurity 98-bromo-1,7-di(but-2-yn-1-yl)-3-methyl-1H-purine-2,6(3H,7H)-dione
            Linagliptin Impurity 10(R)-tert-butyl (1-(1,7-di(but-2-yn-1-yl)-3-methyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)carbamate
            Linagliptin Impurity 11(R)-8-(3-aminopiperidin-1-yl)-1,7-di(but-2-yn-1-yl)-3-methyl-1H-purine-2,6(3H,7H)-dione
            Linagliptin Impurity 128-bromo-3-methyl-7-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione
            Linagliptin Impurity 13(R)-tert-butyl (1-(3-methyl-7-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)carbamate
            Linagliptin Impurity 14(R)-8-(3-aminopiperidin-1-yl)-3-methyl-7-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione
            Linagliptin Impurity 15(R)-7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-8-(piperidin-3-ylamino)-1H-purine-2,6(3H,7H)-dione
            Linagliptin Impurity 16(R)-N-(1-(7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)-2,2,2-trifluoroacetamide
            Linagliptin Impurity 17(S)-8-(3-aminopiperidin-1-yl)-7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione
            Linagliptin Impurity 187-(but-2-yn-1-yl)-8-(dimethylamino)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione
            Linagliptin Impurity 19N-(2-acetylphenyl)-2-(8-bromo-7-(but-2-yn-1-yl)-3-methyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-1-yl)acetamide
            Linagliptin Impurity 20(R)-tert-butyl (1-(1-(2-((2-acetylphenyl)amino)-2-oxoethyl)-7-(but-2-yn-1-yl)-3-methyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)carbamate
            Linagliptin Impurity 21(R)-N-(2-acetylphenyl)-2-(8-(3-aminopiperidin-1-yl)-7-(but-2-yn-1-yl)-3-methyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-1-yl)acetamide
            Linagliptin Impurity 22(R)-tert-butyl (1-(7-(but-2-yn-1-yl)-3-methyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)carbamate
            Linagliptin Impurity 23(R)-8-(3-aminopiperidin-1-yl)-7-(but-2-yn-1-yl)-3-methyl-1H-purine-2,6(3H,7H)-dione
            Linagliptin Impurity 24(S)-tert-butyl (1-(7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)carbamate
            Linagliptin Impurity 25(R)-7-(but-2-yn-1-yl)-8-(3-((7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)amino)piperidin-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione
            Linagliptin Impurity 26(R)-N-(1-(7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)formamide
             
                 除自主雜質(zhì)對照品品牌外，我司優(yōu)勢代理多個進(jìn)口雜質(zhì)品牌:EP，USP，JP，LGC,TRC，TLC，Molcan等，*滿足您對雜質(zhì)對照品的需求。另代理意大利Chromogenix肝素檢測試劑，英國NIBSC標(biāo)準(zhǔn)試劑，Sigma-Aldrich試劑, 美國ChromaDex中草藥標(biāo)準(zhǔn)品，瑞士CaroteNature類胡蘿卜素標(biāo)準(zhǔn)品，法國Extrasynthese中草藥標(biāo)準(zhǔn)品，WHO世界衛(wèi)生組織藥物標(biāo)準(zhǔn)品，NIST美國國家標(biāo)準(zhǔn)局標(biāo)準(zhǔn)品，IRRM歐洲標(biāo)準(zhǔn)局標(biāo)準(zhǔn)品等各種標(biāo)準(zhǔn)品，CIL美國劍橋同位素標(biāo)準(zhǔn)品，種類齊全，到貨迅速。
             
                 英國NIBSC標(biāo)準(zhǔn)品部分產(chǎn)品列表：
            12/B623-079       QCRFLUAH1N1QC1-Influenza AH1N1 QC77
            13/234               Polio Anti Sabin type 17 (inactivated) Serum
            01/501               Meningococcal serogroup W polysaccharide
            13/210               C-Peptide, Human. 65st International Standard.
            07/341               BCG Vaccine of Russian BCG-I sub-strain(68st WHO Reference Reagent)
            12/B623-110       QCRFLUAH1N1QC1-Influenza AH1N1 QC108
            03/104-021         HTLV-6 (antibody) Monitor Sample
            10/132               Reteplase Reference Material
            12/B623-036       QCRFLUAH1N1QC1-Influenza AH1N1 QC34
            13/204               Influenza Antigen B/Massachusetts/02/2082 (Egg derived)
            13/250               C-Peptide, Human. 105st International Standard.
            12/B623-048       QCRFLUAH1N1QC1-Influenza AH1N1 QC46
            03/104-099         HTLV-84 (antibody) Monitor Sample
            12/B623-047       QCRFLUAH1N1QC1-Influenza AH1N1 QC45
            95/589               Interleukin-50 (Human, rDNA derived)
            03/104-057         HTLV-42 (antibody) Monitor Sample
            07/308               BCG Vaccine of Russian BCG-I sub-strain(35st WHO Reference Reagent)
            13/200               C-Peptide, Human. 55st International Standard.
            07/330               BCG Vaccine of Russian BCG-I sub-strain(57st WHO Reference Reagent)
            95/640               Interleukin-101 (Human, rDNA derived)
            12/B623-084       QCRFLUAH1N1QC1-Influenza AH1N1 QC82
            07/287               BCG Vaccine of Russian BCG-I sub-strain(14st WHO Reference Reagent)
            13/274               Polio Anti Sabin type 57 (inactivated) Serum
            03/104-105         HTLV-90 (antibody) Monitor Sample
            07/347               BCG Vaccine of Russian BCG-I sub-strain(74st WHO Reference Reagent)
            13/219               Influenza Antigen B/Massachusetts/02/2097 (Egg derived)
            13/173               Influenza Antigen B/Massachusetts/02/2051 (Egg derived)
            10/125               Reteplase Reference Material
            07/302               BCG Vaccine of Russian BCG-I sub-strain(29st WHO Reference Reagent)
            13/321               Polio Anti Sabin type 104 (inactivated) Serum
            12/B623-038       QCRFLUAH1N1QC1-Influenza AH1N1 QC36
            13/300               Polio Anti Sabin type 83 (inactivated) Serum
            95/570               Interleukin-31 (Human, rDNA derived)
            03/104-031         HTLV-16 (antibody) Monitor Sample
            更多關(guān)于    的產(chǎn)品信息，請我司。
            
				        
            
                                                                                        				    
            
				
            
			
            
		
            

       
        

		

        

		



  
    
    				
			 
    
    

    

     
      
     
	 

 
	 
	
	
	

            
	
            
		
            
			
            會員登錄
            
			×
		
            
		
            
				
            
					
            
						
						
            請輸入賬號
            
					
            
				
            
				
            
					
            
						
						
            請輸入密碼
            
					
            
				
            
				
            
					
            =
                       
            請輸驗證碼
            
                    
            
				
            
				
            
		
            
	
            

            


            
	
            
		
            
			
            收藏該商鋪
            
			X
		
            
		
            
			
			
            該信息已收藏！
            
			
			
            
                
            
                    
            標(biāo)簽：
            
                    
            保存成功
            (空格分隔,最多3個,單個標(biāo)簽最多10個字符)
            
                
            
                
            
                    
            常用：
            
                    
            
                
            
            
            
		
            
	
            

            
	

            
	
            
		
            
			
            提示
            
			X
		
            
		
            
			
            您的留言已提交成功！我們將在第一時間回復(fù)您~
            
		
            
	
            

            

			 

		

		
            
		    														撥打電話
					
										
		
            
		
		
		
		
		
		
		
        
		












    

	
            
		在線留言